Product

Company

NCT03867734·1 site·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Washington

Age

16–any

Sex

ALL

Healthy volunteers

Accepted

Persons diagnosed with pharyngeal gonorrhea or gonococcal urethritis who are undergoing pharyngeal gonorrhea testing, who are not yet treated.

Age less than 16 years
Receipt of antibiotics in ≤30 days
Known allergy to aztreonam
History of renal disease (including diagnosis of solitary kidney, chronic renal insufficiency, renal cell carcinoma etc.)
Concurrent infection with syphilis or chlamydia
Pregnancy and/or nursing
Unable to return for a follow-up visit 4-7 days (+/- 1 day).
Study team's discretion

The record

StatusCompleted

PhasePhase 2–3

Taking part32

StartedApr 2019

UpdatedJan 18, 2022

Conditions

Where1

Public Health -- Seattle & King County STD Clinic
Seattle, Washington, United States

Clareo Health | Aztreonam for Pharyngeal Gonorrhea